GE Healthcare and Varian, Inc. Announce Pre-Clinical Magnetic Resonance Imaging (MRI) System
PALO ALTO, Calif., May 12 /PRNewswire-FirstCall/ -- GE Healthcare and Varian, Inc. announce the availability of the Discovery(TM) MR901, a new pre-clinical 7T magnetic resonance imaging (MRI) system which provides new capabilities for a broad range of research objectives.
The Discovery MR901 combines GE Healthcare's state-of-the-art diagnostic technology with Varian's leading scientific platform to provide a pre-clinical MRI system for the scientific community. The pre-clinical technology aims to excel in soft tissue contrast and non-invasive techniques, including those used in research for anatomy, metabolism, and physiology in research models.
"Our offering provides a new level of depth and versatility to the scientific community," said Jim Davis, Vice President and General Manager of Magnetic Resonance, GE Healthcare. "This introduction provides the opportunity to strengthen our footprint within clinical research while complementing our existing portfolio."
The range of preclinical MRI applications includes brain and organ imaging, tumor assessment, disease progression and functional imaging. Other potential research applications include investigation of new contrast mechanisms and agents, monitoring gene expression, analysis of protein interactions, and determination of pharmacokinetics.
Varian and GE Healthcare announced the Discovery MR901 at the International Society for Magnetic Resonance in Medicine (ISMRM) conference in Honolulu, Hawaii. The first unit is ready for shipment pending completion of the customer site.
"I am very pleased with how the system integration has progressed. The first system is expected to ship this summer, adding to our installed-base of leading MRI and NMR instrumentation," said David Rayner, Vice President of Research Products at Varian.
For more technical information about Varian products, please visit http://www.varianinc.com/products/
About Varian, Inc.:
Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,700 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.
About GE Healthcare:
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre- symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE - News). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at http://www.gehealthcare.com.
For More Information, Contact: Public Relations Varian, Inc. (925) 942-4703 pr@varianinc.com
GE Healthcare, Wauwatosa Jennifer Francis (847) 277-4427 Jennifer.N.Francis@ge.com